购物车
全部删除
您的购物车当前为空
GPR183-IN-2 (compound 23) 作为一种有效口服活性GPR183抑制剂,能够抑制Ca2+动员,其IC50为39.45 nM。该化合物在癌症、自身免疫疾病、疼痛及骨质疏松症研究中显示出潜在应用价值。

GPR183-IN-2 (compound 23) 作为一种有效口服活性GPR183抑制剂,能够抑制Ca2+动员,其IC50为39.45 nM。该化合物在癌症、自身免疫疾病、疼痛及骨质疏松症研究中显示出潜在应用价值。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
GPR183-IN-2 相关产品
| 产品描述 | GPR183-IN-2 (compound 23) is an effective, orally active inhibitor of GPR183, displaying an IC50 value of 39.45 nM in Ca2+ mobilization assays. This compound has potential applications in research related to cancer, autoimmune diseases, pain, and osteoporosis. |
| 分子量 | 407.3 |
| 分子式 | C19H23BrN2O3 |
| CAS No. | 2924064-10-6 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容